[1] |
Kirschner LS, Carney JA, Pack SD, et al. Mutations of the gene encoding the protein kinase A typeⅠ⁃alpha regulatory subunit in patients with the Carney complex[J]. Nat Genet, 2000,26(1):89⁃92. doi: 10.1038/79238.
|
[2] |
Zawadzki KM, Taylor SS. cAMP⁃dependent protein kinase regulatory subunit typeⅡbeta: active site mutations define an isoform⁃specific network for allosteric signaling by cAMP[J]. J Biol Chem, 2004,279(8):7029⁃7036. doi: 10.1074/jbc.M3108 04200.
|
[3] |
Guo H, Xu J, Xiong H, et al. Case studies of two related Chinese patients with Carney complex presenting with extensive cardiac myxomas and PRKAR1A gene mutation of c.491_492delTG[J]. World J Surg Oncol, 2015,13:83. doi: 10.1186/s12957⁃015⁃0470⁃4.
|
[4] |
Bertherat J, Horvath A, Groussin L, et al. Mutations in regulatory subunit type 1A of cyclic adenosine 5'⁃monophosphate⁃dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes[J]. J Clin Endocrinol Metab, 2009,94(6):2085⁃2091. doi: 10.1210/jc.2008⁃2333.
|
[5] |
Espiard S, Bertherat J. Carney complex[J]. Front Horm Res, 2013,41:50⁃62. doi: 10.1159/000345669.
|
[6] |
Ma S, Liu W, Zhang A, et al. Identification of a PRKAR1A mutation (c.491_492delTG) in familial cardiac myxoma: a case report[J]. Medicine (Baltimore), 2019,98(11):e14866. doi: 10. 1097/MD.0000000000014866.
|
[7] |
Tsurutani Y, Kiriyama K, Kondo M, et al. Carney complex complicated with primary pigmented nodular adrenocortical disease without Cushing's syndrome recurrence for five years after unilateral adrenalectomy[J]. Intern Med, 2022,61(2):205⁃211. doi: 10.2169/internalmedicine.7418⁃21.
|
[8] |
班茹, 张风玉, 赵鑫, 等. PRKAR1A基因突变所致Carney综合征并发脑出血和多发性颅内动脉瘤: 1例报道并文献复习[J]. 国际脑血管病杂志, 2019,27(9):711⁃716. doi: 10.3760/cma.j.issn.1673⁃4165.2019.09.014.
|
[9] |
Veugelers M, Wilkes D, Burton K, et al. Comparative PRKAR1A genotype⁃phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice[J]. Proc Natl Acad Sci U S A, 2004,101(39):14222⁃14227. doi: 10.1073/pnas.0405535101.
|
[10] |
Tirosh A, Auerbach A, Bonella B, et al. Failure to thrive in the context of Carney complex[J]. Horm Res Paediatr, 2018,89(1):38⁃46. doi: 10.1159/000484690.
|
[11] |
Kirschner LS, Kusewitt DF, Matyakhina L, et al. A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP⁃responsive tissues[J]. Cancer Res, 2005,65(11):4506⁃4514. doi: 10.1158/0008⁃5472.CAN⁃05⁃0580.
|
[12] |
Horvath A, Stratakis CA. Carney complex and lentiginosis[J]. Pigment Cell Melanoma Res, 2009,22(5):580⁃587. doi: 10.1111/j.1755⁃148X.2009.00613.x.
|
[13] |
Siordia JA. Medical and surgical management of Carney complex[J]. J Card Surg, 2015,30(7):560⁃567. doi: 10.1111/jocs.12575.
|
[14] |
Carney JA, Lyssikatos C, Seethala RR, et al. The spectrum of thyroid gland pathology in Carney complex: the importance of follicular carcinoma[J]. Am J Surg Pathol, 2018,42(5):587⁃594. doi: 10.1097/PAS.0000000000000975.
|
[15] |
Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation[J]. J Clin Endocrinol Metab, 2001,86(9):4041⁃4046. doi: 10.1210/jcem.86.9.7903.
|